FATE
Fate Therapeutics Inc. (FATE)
NASDAQ · Healthcare
Fate Therapeutics Inc. annual/quarterly long term debt history from 2012 to 2018. Long term debt refers to financial obligations that are due more than one year in the future.
- Fate Therapeutics Inc. long term debt for the quarter ending December 31, 2018 were 18.5M, a 4.34% decrease year-over-year.
- Fate Therapeutics Inc. long term debt for 2018 were 18.5M, a 4.34% decrease from 2017.
- Fate Therapeutics Inc. long term debt for 2017 were 19.3M, a 50.79% increase from 2016.
- Fate Therapeutics Inc. long term debt for 2016 were 12.8M, a 40.60% decrease from 2015.
- Fate Therapeutics Inc. long term debt for 2015 were 21.6M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Fate Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2018 | $18 |
| 2017 | $19 |
| 2016 | $13 |
| 2015 | $22 |
| 2013 | $2 |
| 2012 | $4 |
| Fate Therapeutics Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2018-12-31 | $18 |
| 2017-12-31 | $19 |
| 2016-12-31 | $13 |
| 2015-12-31 | $22 |
| 2013-12-31 | $2 |
| 2012-12-31 | $4 |
Fate Therapeutics Inc. Long Term Debt — FAQ
Fate Therapeutics Inc. (FATE) long term debt over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FATE's long term debt history?
The chart and table above show Fate Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.